1. Home
  2. NNDM vs ALT Comparison

NNDM vs ALT Comparison

Compare NNDM & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNDM
  • ALT
  • Stock Information
  • Founded
  • NNDM 2012
  • ALT 1997
  • Country
  • NNDM United States
  • ALT United States
  • Employees
  • NNDM N/A
  • ALT N/A
  • Industry
  • NNDM Electrical Products
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNDM Technology
  • ALT Health Care
  • Exchange
  • NNDM Nasdaq
  • ALT Nasdaq
  • Market Cap
  • NNDM 334.6M
  • ALT 292.0M
  • IPO Year
  • NNDM N/A
  • ALT N/A
  • Fundamental
  • Price
  • NNDM $1.40
  • ALT $3.83
  • Analyst Decision
  • NNDM
  • ALT Strong Buy
  • Analyst Count
  • NNDM 0
  • ALT 6
  • Target Price
  • NNDM N/A
  • ALT $17.40
  • AVG Volume (30 Days)
  • NNDM 1.4M
  • ALT 3.0M
  • Earning Date
  • NNDM 09-09-2025
  • ALT 08-12-2025
  • Dividend Yield
  • NNDM N/A
  • ALT N/A
  • EPS Growth
  • NNDM N/A
  • ALT N/A
  • EPS
  • NNDM N/A
  • ALT N/A
  • Revenue
  • NNDM $58,812,000.00
  • ALT $20,000.00
  • Revenue This Year
  • NNDM N/A
  • ALT N/A
  • Revenue Next Year
  • NNDM N/A
  • ALT $761,880.20
  • P/E Ratio
  • NNDM N/A
  • ALT N/A
  • Revenue Growth
  • NNDM 7.49
  • ALT N/A
  • 52 Week Low
  • NNDM $1.31
  • ALT $2.90
  • 52 Week High
  • NNDM $2.74
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • NNDM 50.50
  • ALT 51.79
  • Support Level
  • NNDM $1.39
  • ALT $3.35
  • Resistance Level
  • NNDM $1.45
  • ALT $3.66
  • Average True Range (ATR)
  • NNDM 0.05
  • ALT 0.19
  • MACD
  • NNDM 0.01
  • ALT 0.07
  • Stochastic Oscillator
  • NNDM 69.12
  • ALT 86.18

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provide industrial manufacturing solutions for design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research and academia, along with government organizations.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: